tirzepatide appetite Reduces Food Intake and Appetite, and Affects Brain Functioning, more than a Placebo and Liraglutide Is Tirzepatide a Game-Changer in

13 In the FDA Adverse Event Reporting System database, 73 cases of ketoacidosis in patients with T1DM or T2DM were reported from March 2013 to May 2015

In a real-world context, this indicates that while a theoretical interaction exists, in practice, the combination is being managed safely under routine clinical care across the UK

Well say it again to make it clear weight loss medication is not a standalone solution

Lancet 2017;390:1664-75.ArticlePubMedPMC 83

The SURMOUNT-4 trial showed that discontinuing tirzepatide after weight loss led to significant weight regain, suggesting continued use is associated with maintained outcomes

Why Weekly Dosing Beats Irregular Schedules for Maintenance Maintenance dosingcontinuing weekly injections after reaching your target weightkeeps GLP-1 activity constant and prevents metabolic adaptation